According to the Zhitong Finance App, Baoji Pharmaceutical-B (02659) announced that on September 1, 2026, the company spent HK$19.942 million to repurchase 119,200 shares at a repurchase price of HK$16.48-16.81 per share.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.